Edition:
United Kingdom

Swiss Market Report Headlines

CORRECTED-Roche raises outlook after H1 beat

Roche, the biggest maker of cancer drugs, raised its 2017 outlook after first-half profit beat market expectations just as the Swiss group's ageing portfolio of blockbuster medicines faces increasing competition from biosimilar copies.

Earlier